Advanced search
Publication Cover
Journal of Drug Targeting Volume 18, 2010 - Issue 6
Submit an article Journal homepage
192
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Novel multifunctional polyethylene glycol-transactivating-transduction protein-modified liposomes cross the blood-spinal cord barrier after spinal cord injury

Yang LiuDepartment of Orthopaedics, Tianjin Medical University General Hospital, Tianjin, PR China
,
Chun-Yuan WangDepartment of Orthopaedics, Tianjin Medical University General Hospital, Tianjin, PR China
,
Xiao-Hong KongMedicine College, NanKai University, Tianjin, P.R. China
,
Han-Jie WangSchool of Materials Science and Engineering, Tianjin University, Tianjin, P.R. China
,
Jin- ChangSchool of Materials Science and Engineering, Tianjin University, Tianjin, P.R. China
,
Da-Peng ZhangDepartment of Orthopaedics, Tianjin Medical University General Hospital, Tianjin, PR China
,
De-Xiang BanDepartment of Orthopaedics, Tianjin Medical University General Hospital, Tianjin, PR China
&
Shi-Qing FengDepartment of Orthopaedics, Tianjin Medical University General Hospital, Tianjin, PR ChinaCorrespondence[email protected]
 show all
Pages 420-429 | Received 16 Jul 2009, Accepted 19 Oct 2009, Published online: 03 Dec 2009

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Shi-Jie Gao, Yang Liu, Han-Jie Wang, De-Xiang Ban, Shi-Zhao Cheng, Guang-Zhi Ning, Liang-Liang Wang, Jin Chang & Shi-Qing Feng. (2017) New approach to treating spinal cord injury using PEG-TAT-modified, cyclosporine-A-loaded PLGA/polymeric liposomes. Journal of Drug Targeting 25:1, pages 75-82.
Read now
Filippo Rossi, Giuseppe Perale, Simonetta Papa, Gianluigi Forloni & Pietro Veglianese. (2013) Current options for drug delivery to the spinal cord. Expert Opinion on Drug Delivery 10:3, pages 385-396.
Read now

Articles from other publishers (18)

Mohammad Amin Rajizadeh, Sina Motamedy, Yousof Mir, Faezeh Akhgarandouz, Mohammad Hadi Nematollahi & Akram Nezhadi. (2023) A comprehensive and updated review on the applications of vesicular drug delivery systems in treatment of brain disorders: A shelter against storms. Journal of Drug Delivery Science and Technology 89, pages 105011.
Crossref
Elisa García, Samantha Sánchez-Noriega, Guadalupe González-Pacheco, Alejandro Naat González-Vázquez, Antonio Ibarra & Roxana Rodríguez-Barrera. (2023) Recent advances in the combination of cellular therapy with stem cells and nanoparticles after a spinal cord injury. Frontiers in Neurology 14.
Crossref
Yasmeen Saeed. (2023) Title: Immunotherapy; a ground-breaking remedy for spinal cord injury with stumbling blocks: An overview. Frontiers in Pharmacology 14.
Crossref
Clare Grady, Kaitlyn Melnick, Ken Porche, Farhad Dastmalchi, Daniel J. Hoh, Maryam Rahman & Ashley Ghiaseddin. (2022) Glioma Immunotherapy: Advances and Challenges for Spinal Cord Gliomas. Neurospine 19:1, pages 13-29.
Crossref
Neha Chopra, Spiro Menounos, Jaesung P. Choi, Philip M. Hansbro, Ashish D. Diwan & Abhirup Das. (2021) Blood-Spinal Cord Barrier: Its Role in Spinal Disorders and Emerging Therapeutic Strategies. NeuroSci 3:1, pages 1-27.
Crossref
Rafaela ZimmermannYuri Vieira AlvesLaura E. SperlingPatricia Pranke. (2021) Nanotechnology for the Treatment of Spinal Cord Injury. Tissue Engineering Part B: Reviews 27:4, pages 353-365.
Crossref
Sajad Fakhri, Fatemeh Abbaszadeh & Masoumeh Jorjani. (2021) On the therapeutic targets and pharmacological treatments for pain relief following spinal cord injury: A mechanistic review. Biomedicine & Pharmacotherapy 139, pages 111563.
Crossref
Mallesh Kurakula, Shashank Gorityala, Devang B. Patel, Pratap Basim, Bhaumik Patel & Saurabh Kumar Jha. (2021) Trends of Chitosan Based Delivery Systems in Neuroregeneration and Functional Recovery in Spinal Cord Injuries. Polysaccharides 2:2, pages 519-537.
Crossref
Indu Venugopal, Ankit I. Mehta & Andreas A. Linninger. 2020. Drug Delivery Systems. Drug Delivery Systems 121 143 .
Vibhu Krishnan Viswanathan, Sakthivel Rajan Rajaram Manoharan, Surabhi Subramanian & Andrew Moon. (2019) Nanotechnology in Spine Surgery: A Current Update and Critical Review of the Literature. World Neurosurgery 123, pages 142-155.
Crossref
Lijie Huang, Jiangnan Hu, Shengwei Huang, Brian Wang, Felix Siaw-Debrah, Mark Nyanzu, Yu Zhang & Qichuan Zhuge. (2017) Nanomaterial applications for neurological diseases and central nervous system injury. Progress in Neurobiology 157, pages 29-48.
Crossref
Jonathan M. Zuidema, Ryan J. Gilbert & Donna J. Osterhout. (2016) Nanoparticle Technologies in the Spinal Cord. Cells Tissues Organs 202:1-2, pages 102-115.
Crossref
TIANYI WANG, YONG LIU, WENQI YUAN, LIANG ZHANG, YANJUN ZHANG, ZHIJIE WANG, XIANHU ZHOU, HENGXING ZHOU, TIANCI CHU, YAN HAO, BIN LIU, XUECHAO ZHAO, LU LU, SHIQING FENG & XIAOHONG KONG. (2015) Identification of microRNAome in rat bladder reveals miR-1949 as a potential inducer of bladder cancer following spinal cord injury. Molecular Medicine Reports 12:2, pages 2849-2857.
Crossref
Ilaria Caron, Simonetta Papa, Filippo Rossi, Gianluigi Forloni & Pietro Veglianese. (2014) Nanovector‐mediated drug delivery for spinal cord injury treatment. WIREs Nanomedicine and Nanobiotechnology 6:5, pages 506-515.
Crossref
Pradeep Kumar, Yahya E Choonara, Girish Modi, Dinesh Naidoo & Viness Pillay. (2014) Nanoparticulate strategies for the five R’s of traumatic spinal cord injury intervention: restriction, repair, regeneration, restoration and reorganization. Nanomedicine 9:2, pages 331-348.
Crossref
Jacqueline Y. Tyler, Xiao-Ming Xu & Ji-Xin Cheng. (2013) Nanomedicine for treating spinal cord injury. Nanoscale 5:19, pages 8821.
Crossref
Viktor Bartanusz, Daniela Jezova, Betty Alajajian & Murat Digicaylioglu. (2011) The blood–spinal cord barrier: Morphology and Clinical Implications. Annals of Neurology 70:2, pages 194-206.
Crossref
James B Delehanty, Kelly Boeneman, Christopher E Bradburne, Kelly Robertson, Jason E Bongard & Igor L Medintz. (2010) Peptides for specific intracellular delivery and targeting of nanoparticles: implications for developing nanoparticle-mediated drug delivery. Therapeutic Delivery 1:3, pages 411-433.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.